InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Spangler Patrick D, 董事. Insider active across 1 company, notably OptimizeRx Corp. Cumulatively, 9 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €626k. Activity tracked since 30 June 2021. The latest transaction was filed on 28 August 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Spangler Patrick D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
11,120 股@ US$17.4926.6% 占其流量Common StockSEC:0001296525-25-000002:0
9,868 股0Common StockSEC:0001628280-25-031021:0
10,061 股0Common StockSEC:0001628280-24-027716:0
4,637 股0Common StockSEC:0001628280-23-029930:0
657 股0Common StockSEC:0001628280-23-010320:0
409 股0Common StockSEC:0001628280-23-000211:0
334 股0Common StockSEC:0001628280-22-025812:0
6,252 股@ US$84.3873.4% 占其流量Common Stock (pursuant to 10B5-1 plan)SEC:0001213900-21-059450:0
407 股0Common StockSEC:0001213900-21-035080:0
9 条申报中的 9 条
About Spangler Patrick D
Spangler Patrick D is Administrateur and Director at OptimizeRx Corp. He has 9 filings in total, and across the 9 sampled filings the activity runs from 2021-06-30 to 2025-09-11, with 0 in buys and 625788 in sells; the most frequent transaction type is Levée d'options.
